Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical delivery system for intraperitoneal hyperthermic chemotherapy.

J S Spratt, R A Adcock, M Muskovin

    Cancer Research
    |February 1, 1980
    PubMed
    Summary

    This study details a novel hyperthermic intraperitoneal chemotherapy (HIPEC) treatment for pseudomyxoma peritonei. The procedure, involving heated chemotherapy infusion, proved safe and well-tolerated for intracavitary cancer therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The influence of vestibular stimulation on metabolism and body composition.

    Diabetic medicine : a journal of the British Diabetic Association·2019
    Same author

    Disrupted salience network functional connectivity and white-matter microstructure in persons at risk for psychosis: findings from the LYRIKS study.

    Psychological medicine·2016
    Same author

    Treponemicidal levels of amoxicillin can be achieved in cerebrospinal fluid following oral treatment with only 4 g amoxicillin and 2 g probenecid daily in late stage syphilis.

    International journal of STD & AIDS·2012
    Same author

    Blackawton bees.

    Biology letters·2010
    Same author

    Electrophysiological and diffusion tensor imaging evidence of delayed corollary discharges in patients with schizophrenia.

    Psychological medicine·2010
    Same author

    Medical complications of an aquatic innovation.

    British journal of sports medicine·2009

    Area of Science:

    • Oncology
    • Surgical Oncology
    • Medical Technology

    Background:

    • Pseudomyxoma peritonei is a rare malignancy requiring advanced treatment strategies.
    • Intracavitary chemotherapy offers a targeted approach for peritoneal surface malignancies.
    • Hyperthermic perfusion systems enable precise temperature control during chemotherapy delivery.

    Observation:

    • A 35-year-old male patient with pseudomyxoma peritonei underwent surgical resection followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
    • The procedure involved instilling lactated Ringer's solution into the peritoneal cavity and warming it to 42°C via a specialized perfusion system.
    • Chemotherapy was administered intraperitoneally once the target temperature was achieved, followed by a second procedure 8 days later.

    Findings:

    Related Experiment Videos

    • The patient's postoperative recovery was largely uneventful, with minor pulmonary atelectasis and bacteremia.
    • Hyperthermic perfusion was well-tolerated and demonstrated safety as an intracavitary cancer treatment modality.
    • This case highlights the feasibility of using a dedicated machine for hyperthermic perfusion in treating peritoneal surface cancers.

    Implications:

    • Hyperthermic intraperitoneal chemotherapy represents a promising therapeutic option for pseudomyxoma peritonei and similar peritoneal malignancies.
    • The specialized perfusion system facilitates safe and effective delivery of heated chemotherapy directly into the peritoneal cavity.
    • Further research into HIPEC may lead to improved outcomes for patients with advanced peritoneal cancers.